Literature DB >> 12620630

Production of unmarked mutations in mycobacteria using site-specific recombination.

Wladimir Malaga1, Esther Perez, Christophe Guilhot.   

Abstract

Gene disruption experiments play an important role in the functional characterization of genes in mycobacteria and rely mostly on the use of one or two antibiotic resistance markers. We have developed a system for mycobacteria which features both the advantages of the use of antibiotic resistance markers for gene disruption experiments and the ability to efficiently rescue the marker leaving an unmarked mutation on the chromosome. This new genetic tool relies on the transposon gammadelta site-specific recombination system. A res-OmegaKm-res cassette was used to generate an insertional mutation by allelic exchange both in Mycobacterium smegmatis and Mycobacterium bovis BCG. Upon expression in the mutated strains of tnpR, the transposon gammadelta resolvase gene, res-OmegaKm-res, was excised efficiently leaving behind a single res sequence at the mutated locus. A plasmid was engineered allowing expression of tnpR from an easily curable mycobacterial vector. This system will be useful for simple construction of unmarked mutations or repeated use of the same antibiotic marker to generate multiple mutants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620630     DOI: 10.1016/S0378-1097(03)00003-X

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  19 in total

1.  Xer site-specific recombination, an efficient tool to introduce unmarked deletions into mycobacteria.

Authors:  Alessandro Cascioferro; Francesca Boldrin; Agnese Serafini; Roberta Provvedi; Giorgio Palù; Riccardo Manganelli
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

2.  The final assembly of trehalose polyphleates takes place within the outer layer of the mycobacterial cell envelope.

Authors:  Laurie Thouvenel; Gautier Prevot; Laura Chiaradia; Julien Parra; Emmanuelle Mouton-Barbosa; Marie Locard-Paulet; Julien Marcoux; Maryelle Tropis; Odile Burlet-Schiltz; Mamadou Daffé; Christophe Guilhot; Gilles Etienne; Christian Chalut
Journal:  J Biol Chem       Date:  2020-06-17       Impact factor: 5.157

3.  Comparative genomics of the Mycobacterium signaling architecture and implications for a novel live attenuated Tuberculosis vaccine.

Authors:  Peifu Zhou; Jianping Xie
Journal:  Hum Vaccin Immunother       Date:  2013-09-06       Impact factor: 3.452

4.  Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes.

Authors:  Guillaume Tabouret; Catherine Astarie-Dequeker; Caroline Demangel; Wladimir Malaga; Patricia Constant; Aurélie Ray; Nadine Honoré; Nana Fatimath Bello; Esther Perez; Mamadou Daffé; Christophe Guilhot
Journal:  PLoS Pathog       Date:  2010-10-21       Impact factor: 6.823

5.  Functional expression of the Flp recombinase in Mycobacterium bovis BCG.

Authors:  Houhui Song; Michael Niederweis
Journal:  Gene       Date:  2007-05-21       Impact factor: 3.688

6.  Conversion of NO2 to NO by reduced coenzyme F420 protects mycobacteria from nitrosative damage.

Authors:  Endang Purwantini; Biswarup Mukhopadhyay
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-26       Impact factor: 11.205

7.  Lipoglycans contribute to innate immune detection of mycobacteria.

Authors:  Shyam Krishna; Aurélie Ray; Shiv K Dubey; Gérald Larrouy-Maumus; Christian Chalut; Romain Castanier; Audrey Noguera; Martine Gilleron; Germain Puzo; Alain Vercellone; K Madhavan Nampoothiri; Jérôme Nigou
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

8.  CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tuberculosis Vaccine Candidate.

Authors:  Luana Moraes; Monalisa Martins Trentini; Dimitrios Fousteris; Silas Fernandes Eto; Ana Marisa Chudzinski-Tavassi; Luciana Cezar de Cerqueira Leite; Alex Issamu Kanno
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

9.  Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia.

Authors:  Wai Yee Phong; Wenwei Lin; Srinivasa P S Rao; Thomas Dick; Sylvie Alonso; Kevin Pethe
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  Functional characterisation of three o-methyltransferases involved in the biosynthesis of phenolglycolipids in Mycobacterium tuberculosis.

Authors:  Roxane Simeone; Gaëlle Huet; Patricia Constant; Wladimir Malaga; Anne Lemassu; Françoise Laval; Mamadou Daffé; Christophe Guilhot; Christian Chalut
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.